Literature DB >> 7270828

Minaxolone: an evaluation with and without premedication.

H G McNeill, R S Clarke, J W Dundee, L P Briggs.   

Abstract

Minaxolone, a water-soluble steroid intravenous anaesthetic, has been used in clinical trials for induction and maintenance in patients presenting for minor operations. A standard induction dose of 0.5 mg/kg was given. There was a low incidence of pain on injection and venous sequelae. Excitatory effects occurred commonly at induction but these were reduced by opiate premedication. The frequency of uneventful induction was significantly greater when the 5 mg/ml solution of minaxolone was given at a rate of 6 ml/minute than at a rate of 24 ml/minute. Minaxolone has been withdrawn from clinical trials following equivocal toxicological findings in rats which require further investigation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7270828     DOI: 10.1111/j.1365-2044.1981.tb10322.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

Review 1.  Synthetic neuroactive steroids as new sedatives and anaesthetics: Back to the future.

Authors:  Francesca M Manzella; Douglas F Covey; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  J Neuroendocrinol       Date:  2022-01-10       Impact factor: 3.627

Review 2.  New drugs--boon or bane? Premedication and intravenous induction agents.

Authors:  R S Clarke
Journal:  Can Anaesth Soc J       Date:  1983-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.